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Abstract
Background: Anti-ganglioside antibodies with a pathogenic potential are present in C. jejuni-associated Guillain-Barre ´
syndrome (GBS) patients and are probably induced by molecular mimicry. Immunization studies in rabbits and mice have
demonstrated that these anti-ganglioside antibodies can be induced using purified lipo-oligosaccharides (LOS) from C. jejuni
in a strong adjuvant.
Methodology/Principal Findings: To investigate whether natural colonization of chickens with a ganglioside-mimicking C.
jejuni strain induces an anti-ganglioside response, and to investigate the diversity in anti-ganglioside response between and
within genetically different chicken lines, we orally challenged chickens with different C. jejuni strains. Oral challenge of
chickens with a C. jejuni strain from a GBS patient, containing a LOS that mimics ganglioside GM1, induced specific IgM and
IgG anti-LOS and anti-GM1 antibodies. Inoculation of chickens with the Penner HS:3 serostrain, without a GM1-like structure,
induced anti-LOS but no anti-ganglioside antibodies. We observed different patterns of anti-LOS/ganglioside response
between and within the five strains of chickens.
Conclusions: Natural infection of chickens with C. jejuni induces anti-ganglioside antibodies. The production of antibodies is
governed by both microbial and host factors.
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Infections in humans with the enteric pathogen Campylobacter jejuni
are able to trigger neurologic sequelae such as the Guillain-Barre ´
(GBS) and Miller Fisher syndrome (MFS) [1]. Neurologic symptoms
are mediated by complement binding anti-ganglioside antibodies [2].
These anti-ganglioside antibodies cross-react with the lipo-oligosac-
charide (LOS) fraction of GBS-associated C. jejuni strains and are
therefore presumed to be induced by molecular mimicry [3].
Immunization of various animal species with purified prepara-
tions of ganglioside-mimicking C. jejuni LOS leads to an anti-
ganglioside response, thereby validating the molecular mimicry
hypothesis [4,5,6]. However, the efficiency of the immunization
procedure is heavily dependent on the use of strong adjuvants,
unlike the situation in GBS and MFS patients, where the anti-
ganglioside antibody response is induced after a natural infection
with C. jejuni. Previous studies have reported the induction of anti-
ganglioside antibodies in chickens following C. jejuni infection but
these have been performed with C. jejuni strains with an
uncharacterized LOS fraction and without non-ganglioside
mimicking control C. jejuni strain [7,8]. A single unconfirmed
study reported the presence of a GBS-like disease in chickens
following inoculation with a C. jejuni strain [9].
Only a very small proportion of C. jejuni infected human
individuals develop GBS or MFS. Bacterial risk factors for the
development of neurological disease identified so far, are genes or
gene polymorphisms located within the LOS gene cluster,
emphasizing the important role of LOS in the pathogenesis of
Campylobacter-related GBS [10,11]. However, family studies
indicate that although multiple individuals can be infected by
the same Campylobacter strain, not all family members develop GBS
[12]. These observations suggest that, in addition to bacterial
traits, host-determined factors play a role in the development of
post-Campylobacter neuropathy.
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9820In the present study, we performed a series of experiments
where we orally challenged several groups of chickens with GBS-
associated strain GB11 in order to answer the following questions.
(i) Is it possible to induce an anti-ganglioside antibody response in
chickens by a natural route of inoculation, as opposed to the non-
physiological adjuvant-dependent immunizations. (ii) Is there any
difference in anti-ganglioside response either between or within
genetically different groups of chickens.
Materials and Methods
Animals
Five genetically different meat-type chicken groups were used
for this experiment. They included two traditional Old Dutch
Breeds, groups 1 (Barnevelder) and 2 (Twentsche Grijzen),
obtained from IPC dier, Barneveld, the Netherlands. Three
modern outbred broiler groups were included, groups E3 (meat-
type), E4 (meat-type but also selected for reproduction) and E5
(offspring of group E36group E4 cross) Groups 3, 4, and 5 were
kindly provided by Euribrid (Herveld, The Netherlands). After
hatch, birds were tested and shown to be free of Campylobacter.
Birds were given feed and water ad libitum. All chickens were
cared for in accordance with accepted procedures of the Dutch
law of animal welfare. The animal experiment committee (DEC,
Dier Experimentele Commissie) from the Central Veterinary
Institute approved all experimental procedures applied to the birds
(ID-Lelystad/CVI, project number 367.47026.00). All experi-
ments were performed in isolators with an absolute separation of
the different groups.
Bacterial strains
C. jejuni strain GB11 was isolated from a patient with GBS with
anti-GM1, anti-GD1b and anti-GA1 antibodies [13,14]. The LOS
structure has been determined previously and was shown to
contain GM1 and GD1a mimics [14]. As a control, the Penner
HS:3 serostrain was used. This LOS of this strain does not mimic
any ganglioside [15]. C. jejuni strains were grown on blood agar
plates, incubated at 37uC under microaerobic conditions.
Inoculation experiments
Chickens were orally challenged at day 15 after hatch with 10*9
cfu of bacteria in 0.5 ml by oral gavage. Per chicken group, 5–12
animals were used. Control animals were orally challenged with
phosphate-buffered saline (PBS). Birds were observed daily for the
development of neurological symptoms. Blood sampling was
performed on days 0, 8, 16, and 21. At day 27 post-inoculation,
the animals were sacrificed, an additional blood sample was taken
and caecal contents were sampled for culture of C. jejuni. Samples
from sciatic nerves of selected animals were fixed in glutaralde-
hyde, post-fixed with osmium tetroxide and embedded in epoxy
resin. Semithin sections were stained with toluidine blue and
investigated with light microscopy. For electron microscopy,
ultrathin sections were stained with uranyl acetate and lead citrate
before examination.
Serological studies
Serum samples were investigated for antibody reactivity against
C. jejuni protein fractions, purified C. jejuni LOS and purified
gangliosides using ELISA. For anti-protein reactivity, C. jejuni
proteins were extracted with acid glycine. ELISA plates (Maxisorp,
NUNC, Roskilde, Denmark) were coated overnight with 5
microgram/ml protein per well in Na2CO3 buffer pH 9.6. Serum
samples were diluted 1:100 in PBS and incubated at 37uC for
1 hour. After washing with PBS containing 0.05% Tween20 (PBS-
Tween) plates were incubated with monoclonal mouse anti-
chicken IgM (CVI-ChIgG 59.7) or IgG (CVI-ChIgM 47.3) diluted
1:10,000 or 1:7,500 in PBS at 37uC for 1 hour. Plates were washed
with PBS-Tween and incubated with anti-mouse total immuno-
globulines conjugated to peroxidase (Dako, Glostrup, Denmark)
diluted 1:1,000 at 37uC for 1 hour. Plates were developed with o-
phenylenediamine, the reaction was stopped by adding 2N HCl
and plates were read at 490 nm.
The LOS fraction of C. jejuni was extracted with hot phenol-
water [16]. Purified freeze dried fractions were weighed and
resuspended in water. For detection of antibodies against C. jejuni
LOS, plates were coated overnight with 1 microgram LOS/well in
PBS as described previously [17]. ELISA was performed as stated
above for the detection of anti- C. jejuni protein antibodies with the
following modifications. Serum incubation was performed at 4uC
overnight, other incubations were also at 4uC. Washing was done
with PBS without Tween. For anti-ganglioside reactivity, plates
were coated with asialo-GM1 (GA1), GM1, GD1b or GQ1b as
described before [17] and anti-ganglioside antibody reactivity was
detected as described above for anti-LOS reactivity.
To assess cross-reactivity, serum from infected chickens was
incubated with Campylobacter LOS conjugated to Octyl-Sepharose
CL4b beads as described previously [3] and absorbed serum
samples were tested for anti-LOS and anti-ganglioside reactivity.
Results
Specificity of the antibody response
For determination of the specificity of the antibody response
following colonization with Campylobacter, chickens from group E4
were orally challenged with GB11, Pen HS:3 or PBS and the
antibody response against proteins, LOS and gangliosides was
determined at 27 days post-inoculation. Campylobacter-challenged
chickens had widely divergent antibody responses against protein
antigens (Fig. 1A, B). There was both an IgM and IgG response
against the protein antigen, but the IgM response was generally
lower than the IgG response (data not shown). In GB11 challenged
chickens, the IgG antibody response against GB11 protein was
slightly stronger than against Pen HS:3 protein (Fig. 1A), but
generally, there was considerable cross-reactivity between groups
of chickens. In contrast, the IgG anti-LOS responses were highly
specific. All Pen HS:3 infected chickens had a strong IgG anti-Pen
HS:3 LOS response, but none of the animals had reactivity against
GB11 LOS (Fig. 1C). Only 2/9 GB11 challenged chickens
mounted a strong IgG response against GB11 LOS (Fig. 1C). This
reactivity was highly specific because these two sera did not have
reactivity against Pen HS:3 LOS.
The anti-ganglioside reactivity in chickens was as would be
expected from the ganglioside-structure of the infecting Campylo-
bacter strain. There was no detectable anti-GM1 reactivity in
chickens that were not orally challenged or chickens that had been
orally challenged with Pen HS:3 (Fig. 1E) The two GB11
challenged chickens with an anti-LPS response also had an anti-
ganglioside response against GA1, GM1 and GD1b, but not
against GQ1b (Fig. 1E, F and data not shown). This pattern of
anti-ganglioside reactivity was identical to that of the patient from
which strain GB11 was isolated. We tested whether the anti-
ganglioside antibodies were indeed induced by molecular mimicry
by absorbing the anti-ganglioside and anti-LOS antibodies with C.
jejuni LOS conjugated to Octyl-sepharose beads. The anti-GM1
and anti-GB11 LOS reactivity could be reduced by 60–90%
following incubation with GB11-coupled sepharose beads but not
by Pen HS:3 coupled beads or beads without LOS, thereby
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shown).
Difference between chicken lines
To investigate the influence of genetic background on the ability
to mount an anti-C. jejuni antibody response, we orally challenged
five chicken lines with C. jejuni strain GB11. Again we found a
strong anti-protein response in all orally challenged chickens but
there were remarkable differences between the groups (Fig. 2). In
serum samples taken before inoculation, there was already a
moderate response against GB11 protein in the Barnevelders but
not in the other groups. This was probably due to passively
transferred maternal antibodies because IgG anti-GB11 protein
levels decreased one week post inoculation to rise again between
two and three weeks post inoculation. The IgG anti-protein
response in E5 chickens appeared one week earlier than for the
Figure 1. IgG antibody responses against C. jejuni antigens. IgG reactivity against C. jejuni proteins (A,B), lipo-oligosaccharides (LOS) (C,D) and
gangliosides GM1 and GQ1b (E,F) in E4 chickens inoculated with C. jejuni strains Pen HS:3 and GB11. Serum was collected at day 27 post-infection.
Each dot represents one chicken.
doi:10.1371/journal.pone.0009820.g001
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PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9820Figure 2. Kinetics of IgG antibody responses against C. jejuni antigens. IgG reactivity against C. jejuni GB11 protein, lipo-oligosaccharide
(LOS) and ganglioside GM1 in five groups of chickens inoculated with C. jejuni GB11. Serum was collected at days 0, 8, 16, 21 and 27 post-infection.
Each line represents one chicken. Serum was not available for all time points for all chickens.
doi:10.1371/journal.pone.0009820.g002
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Barnevelders had a different pattern of response. This group
showed slowly increasing IgM anti-protein levels whereas in the
other groups the IgM levels rose steeply in the second week
following inoculation and declined after three weeks (data not
shown).
The IgG anti-LOS response was stronger in three of five
individual Barnevelders and appeared earlier than in the other
groups. In most Barnevelders, there was a strong IgG anti-GB11
LOS response detectable two weeks post-inoculation, whereas in
the other groups, the anti-LOS response lagged one to two weeks
(Fig 2). In addition to detectable anti-protein responses before oral
challenge, two out of five of the Barnevelders also had detectable
anti-LOS reactivity in the pre-infection samples. Interestingly, the
chickens with the highest pre-challenge anti-LOS antibody level,
had only modest responses post-infection. Similar to the anti-
protein antibodies, the anti-LOS antibody level also decreased in
the first week after infection and increased subsequently.
The anti-ganglioside reactivity also showed a differential pattern
between groups of chickens. The Barnevelders had the earliest
detectable anti-GM1 antibodies and also the proportion of
chickens with an anti-ganglioside response was higher in the
Barnevelders than in the other animals (Fig. 2). None of the
chickens of the E3 group had detectable IgG anti-GM1 reactivity.
The Barnevelders and Twentsche Grijzen were the only groups
with a substantial IgM anti-GM1 response (data not shown).
Difference within chicken lines
In addition to a widely divergent antibody response to
Campylobacter antigens and gangliosides between chicken lines, we
also observed large differences within chicken lines. In all
experiments, the antibody response varied widely within chicken
lines, irrespective of the type of antigen (Fig 1,2). This ranged from
the complete absence of IgG antibody reactivity against GM1 in
seven out of nine GB11 challenged E4 chickens (Fig 1E) to a
continuous range of antibody reactivity against protein antigens in
several groups of chickens (Fig 1A,B, Fig 2).
In one experiment, the chickens developed clinical symptoms
compatible with damage to peripheral nerves. The chickens had
weakness of legs and wings. The attack rate was 1/5 in the E3
group, 3/5 in the E4 group and 3/5 in the E5 group. However,
histopathological analysis of sciatic nerves of these chickens did not
reveal any abnormalities, especially no demyelination or axonal
degeneration. Furthermore, there was no relation between
presence and magnitude of the anti-ganglioside response and the
presence of neurological symptoms. Additional testing for infection
with Marek’s disease virus in these chickens was negative.
Quantitative culture of caecal contents for C. jejuni revealed that
the E4 chickens had the highest colonization level (Fig 3). When
data from all chickens were analyzed together, there was no
relation between colonization level and magnitude of the antibody
response against protein or glycolipid antigens (LOS and
gangliosides). However, within the E4 and E5 groups, C. jejuni
counts in caecal content were highest in chickens with the
strongest antibody response against glycolipid antigens (data not
shown).
Discussion
We demonstrated that chickens mount a cross-reactive anti-
Campylobacter LOS/ganglioside response following natural coloni-
zation with a ganglioside mimicking C. jejuni strain from a GBS
patient. The anti-ganglioside response was specific and the kinetics
and strength of the anti-ganglioside response differed between and
within groups of genetically diverse chickens.
The specificity of the anti-ganglioside response in chickens was
similar to that in the patient from which GB11 was cultured. In
addition, absorption studies demonstrated cross-reactivity between
anti-LOS and anti-ganglioside antibodies, indicating that in both
chickens and GBS patient, the antibodies were induced by
molecular mimicry. The kinetics of the anti-ganglioside response
in chickens was also similar to that observed in GBS patients. In
both chickens and GBS patients, the anti-ganglioside responses
peak between two and four weeks following inoculation with C.
jejuni. No anti-ganglioside antibodies were formed following
inoculation with Pen HS:3, although in chickens infected with
Pen HS:3, there was a strong antibody response against both Pen
HS:3 protein and LOS. Together with the consistent absence of
anti-GM1 response in PBS and HS:3 orally challenged animals, it
can be concluded that the anti-ganglioside antibodies are
specifically induced by inoculation with a ganglioside-mimicking
C. jejuni strain. Immunization studies of mice and rabbits with
Campylobacter LOS in strong adjuvants reached similar conclusions
and our results are in accordance with these studies [3,4,6].
Usuki et al. described the induction of anti-GM1 antibodies in
chickens following inoculation with multiple C. jejuni strains,
including strain 81116 [8]. The exact LOS structure of these
strains has not been determined but it is known that C. jejuni 81116
does not express a GM1 structure [18]. Surprisingly, Usuki et al.
describe the presence of anti-GM1 antibodies following inocula-
tion with C. jejuni 81116 [8]. The authors did not perform any
absorption studies and therefore it remains unclear whether the
anti-ganglioside antibodies that were detected in their study are
truly cross-reactive with C. jejuni LOS.
We observed differences between chicken strains in frequency of
development of anti-ganglioside antibodies, the kinetics of the
antibody response, and colonization following inoculation of
animals with strain GB11. Although the numbers of animals per
group were small and there was variation within each group, we
think that our data clearly demonstrate that, in addition to
bacterial properties, host derived factors influence the anti-
Figure 3. Germ counts in caecal contents of five groups of
chickens inoculated with C. jejuni GB11. Bars indicate mean cfu/per
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of genetically based differences between the groups of chickens in
handling and processing of bacterial antigens by the immune
system [19]. Experiments investigating disease resistance of
Salmonella found that Barnevelders had an increased caecal
content of Salmonella when compared to the broiler groups [20].
However, the Barnevelders were able to clear the infection
whereas the broilers even had a slight increase of Salmonella in the
caecum. Furthermore, the Barnevelders also had the highest levels
of anti-Salmonella antibodies [20]. In our experiments, the
Barnevelders had the strongest antibody response against C. jejuni,
and the lowest level of caecal colonization at 27 days, suggesting a
general enhanced immune response towards colonizing bacteria in
these chickens.
Previous exposure to pathogens may be another determining
factor in the generation of anti-ganglioside antibodies following
inoculation with C. jejuni. The immune system is shaped by
continuous encounters with microbial flora. Passively transferred
maternal anti-C. jejuni antibodies may have influenced the kinetics
and strength of the anti-C. jejuni response in Barnevelders, leading
to an earlier and stronger anti-ganglioside response [21].
We observed a large variation in antibody response and caecal
colonization within chicken lines. This reflects the situation in
humans [12]. The chicken lines used for these experiments are all
outbred lines and thus there is considerable genetic variation
between individual chickens of a single line. Studies into the
influence of gene polymorphisms in immune response genes on
Salmonella colonization of chickens found associations with multiple
polymorphisms on colonization, even within groups of chickens
[20]. Alternatively, differences in anti-ganglioside antibody
formation may have been influenced by bacterial factors. Our
observation that in some broiler groups, animals with high caecal
bacterial counts have the strongest anti-glycolipid response
suggests a threshold mechanism with respect to production of
anti-glycolipid antibodies. Furthermore, transcription profiling has
demonstrated a huge variation in expression of bacterial genes,
including those associated with increased virulence [22]. Finally,
differential expression of ganglioside mimics by Campylobacter cells
during infection may also have been caused by phase variation in
genes coding for enzymes involved in lipo-oligosaccharide
synthesis [23].
Combined, these findings suggest that genetic differences within
lines may be responsible for the variation in anti-ganglioside
responses within groups. In this respect, a familial outbreak of
Campylobacter diarrhoea with only one GBS case, illustrates that
Campylobacter infections in genetically related human individuals
can also have very different outcomes [12].
In one experiment the chickens developed neurological
symptoms. We ruled out a concurrent infection with Marek’s
disease virus. Histopathological investigations of the nerves did not
reveal any abnormalities, in contrast to one earlier study that
described the presence of severe axonal degeneration in post-C.
jejuni paralysed chickens [9]. Furthermore, there was no relation
between the presence of neurological symptoms and circulating
anti-ganglioside antibodies. Therefore, we can not completely rule
out that the symptoms have been induced by C. jejuni induced anti-
ganglioside antibodies but this seems highly unlikely.
In conclusion, we have shown that natural colonization with a
GBS-associated C. jejuni strain is able to induce specific cross-
reactive anti-LOS/ganglioside antibodies. Furthermore, the qual-
itative and quantitative differences between and within groups of
chickens emphasize host-dependent factors in the generation of
anti-ganglioside antibodies following C. jejuni inoculation and make
the chicken infection model suited for studying the pathogenesis of
GBS following C. jejuni infection.
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